Výsledky vyhledávání

Using prognosis to guide inclusion criteria, define standardised endpoints and stratify follow-up in active surveillance for prostate cancer

Autor: Artitaya Lophatananon, José Rubio-Briones, Kenneth Muir, David Thurtle, Ola Bratt, Par Statin, Tristan Barrett, Vincent J. Gnanapragasam, Vineetha Thankapannair, J. Domínguez-Escrig

Publikováno v: BJU International. 124:758-767

Objectives To test whether using disease prognosis can inform a rational approach to active surveillance (AS) for early prostate cancer. Patients and methods We previously developed the Cambridge Prognostics Groups (CPG) classification, a five-tiered

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6bff21327608021517dfbbf2113e7526
https://doi.org/10.1111/bju.14800

Zobrazit plný text záznamu

Plný text ve formátu HTML

Using prognosis to guide inclusion criteria, define standardised endpoints and stratify follow-up in active surveillance for prostate cancer

Autor: Vincent J, Gnanapragasam, Tristan, Barrett, Vineetha, Thankapannair, David, Thurtle, Jose, Rubio-Briones, Jose, Domínguez-Escrig, Ola, Bratt, Par, Statin, Kenneth, Muir, Artitaya, Lophatananon

Publikováno v: BJU internationalReferences. 124(5)

To test whether using disease prognosis can inform a rational approach to active surveillance (AS) for early prostate cancer.We previously developed the Cambridge Prognostics Groups (CPG) classification, a five-tiered model that uses prostate-specifi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d8b7b21091d943cdbfe12ccbeab4124f
https://pubmed.ncbi.nlm.nih.gov/31063245

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání